Muscle Pain Treatment Market Report 2026

Muscle Pain Treatment Market Overview

• Muscle Pain Treatment market size has reached to $13.59 billion in 2025 • Expected to grow to $17.42 billion in 2030 at a compound annual growth rate (CAGR) of 5% • Growth Driver: Impact Of Rising Musculoskeletal Disorders On The Muscle Pain Treatment Market • Market Trend: Innovative Solutions Driving Growth In The Muscle Pain Treatment Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Muscle Pain Treatment Market?

Muscle pain treatment refers to the management and alleviation of discomfort and inflammation affecting muscles. It typically involves rest, application of heat or cold therapy, over-the-counter pain relievers, and sometimes physical therapy or prescription medications for severe cases. The effective treatment aims to reduce pain, promote healing, and restore normal muscle function. The main pharmacological treatments for muscle pain treatment are analgesics, muscle relaxants, topical analgesics, and others. Analgesics refer to medications designed to relieve pain without causing loss of consciousness. Non-pharmacological treatments include physical therapy, massage therapy, acupuncture, heat and cold therapy, exercise and stretching, and others. These treatments address different types of pain, including acute muscle pain and chronic muscle pain caused by overuse and strain, injury or trauma, inflammatory conditions, neurological conditions, infections, and others. They are applied in settings such as hospitals, clinics, and others.

What Is The Muscle Pain Treatment Market Growth Forecast?

The muscle pain treatment market size is expected to see strong growth in the next few years. It will grow to $17.42 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to advancement in topical formulations, rising demand for personalized pain management, increasing use of muscle relaxants in clinical care, expansion of physiotherapy centers, growing investment in alternative pain therapies. Major trends in the forecast period include growing demand for topical analgesic products, rising usage of muscle relaxants for acute pain, increasing adoption of physical and massage therapy, expansion of over-the-counter pain relief products, growing focus on combination therapy for chronic muscle pain.

What Is The Driver Of The Muscle Pain Treatment Market?

The increasing prevalence of musculoskeletal disorders is expected to drive the muscle pain treatment market going forward. Musculoskeletal disorders refer to conditions affecting the muscles, bones, and joints of the body, often causing pain, stiffness, and impaired movement. The rise in musculoskeletal cases is attributed to factors such as aging populations, sedentary lifestyles, and the increasing prevalence of chronic conditions. Muscle pain treatment aims to alleviate symptoms of musculoskeletal disorders by reducing pain, improving mobility, preventing complications, and enhancing patients' overall quality of life and functional abilities. For instance, in January 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, in 2023, 18.4% of people aged 16 and over reported having a long-term musculoskeletal condition, up slightly from 17.6% in 2022. These conditions were reported less frequently by males (15.8%) compared with females (20.9%). Therefore, the increasing prevalence of musculoskeletal disorders is driving the muscle pain treatment industry.

Key Players In The Global Muscle Pain Treatment Market

Major companies operating in the muscle pain treatment market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Baxter International Inc., Haleon Plc, Select Medical Holdings Corporation, Purdue Pharma, Endo Pharmaceuticals Inc., Concentra Inc., Athletico Physical Therapy, ATI Physical Therapy Inc., Physiotherapy Associates Inc, NovaCare Rehabilitation Inc, CORA Health Services Inc., Select Physical Therapy Holdings Inc., ProActive Physical Therapy

Global Muscle Pain Treatment Market Trends and Insights

Major companies operating in the muscle pain treatment market are focused on developing innovative solutions, such as topical analgesic products, to enhance efficacy and user convenience. Topical analgesic products are medications applied directly to the skin to relieve pain by targeting the affected area and are commonly used for conditions such as muscle aches, arthritis, and minor injuries. For instance, in July 2024, Wellness Formulations LLC, a US-based company providing health and wellness products, launched Ralli Rapid Pain Relief, a new product featuring menthol's pain-relieving benefits combined with advanced penetration enhancers and skin conditioners. It delivers effective pain relief without leaving a greasy residue, offering quick and lasting relief from muscle aches, joint pain, arthritis, strains, and sprains. Available in gel, spray, and roll-on formats, it provides convenient application directly to the affected area, eliminating the need for rubbing or massaging.

What Are Latest Mergers And Acquisitions In The Muscle Pain Treatment Market?

In November 2025, Physician Partners of America (PPOA), a US-based provider of interventional pain management, chronic pain care, and related musculoskeletal treatment services, acquired Crespo Injury Care Center for an undisclosed amount. With this acquisition, PPOA aims to expand its geographic footprint in the Tampa Bay region and strengthen access to high-quality interventional pain and musculoskeletal care for a broader patient population. Crespo Injury Care Center is a US-based provider of injury-focused pain management, sports medicine, orthopedic care, and rehabilitation services.

What Defines the Muscle Pain Treatment Market?

The muscle pain treatment market consists of revenues earned by entities by providing services such as chiropractic care, hydrotherapy, occupational therapy, transcutaneous electrical nerve stimulation (TENS), cognitive-behavioral therapy (CBT), and myofascial release therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The muscle pain treatment market also includes sales of acetaminophen, corticosteroids, and nonsteroidal anti-inflammatory drugs (NSAIDs). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Muscle Pain Treatment Market Report 2026?

The muscle pain treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the muscle pain treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.